Mesoblast Ltd. Proposes New Securities Issue
Ticker: MEOBF · Form: 6-K · Filed: Mar 21, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Mar 21, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: securities-issue, capital-raise, foreign-issuer
TL;DR
MESO proposing new shares, watch for dilution or capital infusion.
AI Summary
On March 14, 2024, Mesoblast Limited filed an Appendix 3B with the Australian Securities Exchange, detailing a proposed issue of securities. The company is incorporated in Australia and its principal executive offices are located in Melbourne, Victoria.
Why It Matters
This filing indicates Mesoblast is seeking to raise capital or restructure its equity, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — Proposed securities issues can signal financial needs or strategic shifts, carrying inherent risks for investors.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- March 14, 2024 (date) — Filing date of Appendix 3B
- Australian Securities Exchange (company) — Exchange where filing was made
- Appendix 3B (document) — Type of filing
FAQ
What is the purpose of the proposed issue of securities by Mesoblast Limited?
The filing does not specify the exact purpose of the proposed issue of securities, only that an Appendix 3B was filed on March 14, 2024, with the Australian Securities Exchange.
When was the Appendix 3B filed?
The Appendix 3B was filed on March 14, 2024.
Where is Mesoblast Limited's principal executive office located?
Mesoblast Limited's principal executive offices are located at Level 38, 55 Collins Street, Melbourne, Victoria, 3000, Australia.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Under which SEC Act is Mesoblast Limited filing this Form 6-K?
Mesoblast Limited is filing this Form 6-K under the Securities Exchange Act of 1934.
Filing Stats: 305 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2024-03-20 21:16:23
Filing Documents
- a2024-03x20appendix2aappen.htm (6-K) — 23KB
- exhibit991appendix3b.htm (EX-99.1) — 7KB
- exhibit992appendix2a.htm (EX-99.2) — 57KB
- exhibit993appendix3b.htm (EX-99.3) — 7KB
- exhibit991appendix3b001.jpg (GRAPHIC) — 71KB
- exhibit991appendix3b002.jpg (GRAPHIC) — 103KB
- exhibit991appendix3b003.jpg (GRAPHIC) — 118KB
- exhibit991appendix3b004.jpg (GRAPHIC) — 144KB
- exhibit991appendix3b005.jpg (GRAPHIC) — 42KB
- exhibit992appendix2a001.jpg (GRAPHIC) — 187KB
- exhibit992appendix2a002.jpg (GRAPHIC) — 159KB
- exhibit992appendix2a003.jpg (GRAPHIC) — 187KB
- exhibit992appendix2a004.jpg (GRAPHIC) — 191KB
- exhibit992appendix2a005.jpg (GRAPHIC) — 163KB
- exhibit992appendix2a006.jpg (GRAPHIC) — 169KB
- exhibit992appendix2a007.jpg (GRAPHIC) — 152KB
- exhibit992appendix2a008.jpg (GRAPHIC) — 139KB
- exhibit992appendix2a009.jpg (GRAPHIC) — 145KB
- exhibit992appendix2a010.jpg (GRAPHIC) — 171KB
- exhibit992appendix2a011.jpg (GRAPHIC) — 186KB
- exhibit992appendix2a012.jpg (GRAPHIC) — 187KB
- exhibit992appendix2a013.jpg (GRAPHIC) — 138KB
- exhibit992appendix2a014.jpg (GRAPHIC) — 147KB
- exhibit992appendix2a015.jpg (GRAPHIC) — 145KB
- exhibit992appendix2a016.jpg (GRAPHIC) — 147KB
- exhibit992appendix2a017.jpg (GRAPHIC) — 153KB
- exhibit992appendix2a018.jpg (GRAPHIC) — 134KB
- exhibit992appendix2a019.jpg (GRAPHIC) — 186KB
- exhibit992appendix2a020.jpg (GRAPHIC) — 96KB
- exhibit993appendix3b001.jpg (GRAPHIC) — 71KB
- exhibit993appendix3b002.jpg (GRAPHIC) — 103KB
- exhibit993appendix3b003.jpg (GRAPHIC) — 102KB
- exhibit993appendix3b004.jpg (GRAPHIC) — 159KB
- exhibit993appendix3b005.jpg (GRAPHIC) — 42KB
- 0001345099-24-000031.txt ( ) — 5792KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated March 21, 2024 INDEX TO EXHIBITS Item 99.1 Appendix 3B of Mesoblast Ltd, dated March 14, 2024 . 99.2 Appendix 2A of Mesoblast Ltd, dated March 18, 2024 . 99.3 Appendix 3B of Mesoblast Ltd, dated March 20, 2024 .